Talk:Mivacurium
From Wikipedia, the free encyclopedia
 |
Mivacurium is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome. |
| Stub | This article has been rated as stub-Class on the quality scale. |
|
|
|
(MIVACRON Injection)
Contents |
[edit] IMPORTANT NOTE
This drug should be administered only by adequately trained individuals familiar with its actions, characteristics, and hazards.
[edit] DESCRIPTION
Mivacurium chloride (MIVACRON)is a short-acting, nondepolarizing skeletal muscle relaxant for intravenous (IV) administration.
[edit] CLINICAL PHARMACOLOGY
Mivacurium chloride binds competitively to cholinergic receptors on the motor end-plate to antagonize the action of acetylcholine, resulting in a block of neuromuscular transmission. This action is antagonized by acetylcholinesterase inhibitors, such as neostigmine. Mivacurium is a short-acting, nondepolarizing skeletal neuromuscular blocking agent which is hydrolyzed by plasma cholinesterase. Mivacurium results in a blockade of neuromuscular transmission by binding competitively with cholinergic receptors on the motor end-plate to antagonize the action of acetylcholine.
[edit] INDICATIONS
Mivacurium chloride is a short-acting neuromuscular blocking agent indicated for inpatients and outpatients, as an adjunct to general anesthesia, to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
